USTR

The changes to the NPPA suggest that the price regulator has been underperforming, when, in fact, it has been sticking close to its government-given mandate. Credit: Reuters

Conflicts of Interest With India’s Health Industry: The Need for Legal Intervention

US Government Finds ‘Make in India’ for Medical Devices Discriminatory

US Makes First Public Comments Against India’s Price Cap on Medical Devices